Evidence map›Paper›PMID 34876685›Full record

ArticleNature cell biology2021

Aberrant chromatin landscape following loss of the H3.3 chaperone Daxx in haematopoietic precursors leads to Pu.1-mediated neutrophilia and inflammation.

Julia P Gerber, Jenny Russ, Vijay Chandrasekar, Nina Offermann, Hang-Mao Lee, Sarah Spear, Nicola Guzzi, Simona Maida, Sundararaghavan Pattabiraman, Ruoyu Zhang and 17 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Nature cell biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Histone methyltransferase SETDB1 safeguards mouse fetal hematopoiesis by suppressing activation of cryptic enhancers.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 7 institutions in 4 countries.

Julia P Gerber *German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Jenny Russ *German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID http://orcid.org/0000-0001-6550-761X
Vijay ChandrasekarGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID http://orcid.org/0000-0002-5452-5107
Nina OffermannGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Hang-Mao LeeGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Sarah SpearBarts Cancer Institute, Queen Mary University of London, London, UK.
Nicola GuzziDivision of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden.
Simona MaidaGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Sundararaghavan PattabiramanGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Ruoyu ZhangGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Amir H KayvanjooLife and Medical Sciences (LIMES) Institute, Developmental Biology of the Immune System, University of Bonn, Bonn, Germany.
Preeta DattaDepartment of Cancer Biology, UCL Cancer Institute, London, UK.
Jagath KasturiarachchiDepartment of Cancer Biology, UCL Cancer Institute, London, UK.
Teresa SpositoGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Natalia IzotovaDepartment of Cancer Biology, UCL Cancer Institute, London, UK.
Kristian HändlerPlatform for Single Cell Genomics and Epigenomics (PRECISE) at the German Center for Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.
Peter D AdamsSanford Burnham Prebys Medical Discovery Institute, La Jolla, USA.ORCID http://orcid.org/0000-0002-0684-1770
Teresa MarafiotiDepartment of Cancer Biology, UCL Cancer Institute, London, UK.
Tariq EnverDepartment of Cancer Biology, UCL Cancer Institute, London, UK.ORCID http://orcid.org/0000-0002-0866-6443
Jörg WenzelDepartment of Dermatology and Allergy, University Medical Center, Bonn, Germany.
Marc BeyerGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID http://orcid.org/0000-0001-9704-148X
Elvira MassLife and Medical Sciences (LIMES) Institute, Developmental Biology of the Immune System, University of Bonn, Bonn, Germany.
Cristian BellodiDivision of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0001-8047-5329
Joachim L SchultzeGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID http://orcid.org/0000-0003-2812-9853
Melania CapassoGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID http://orcid.org/0000-0001-8659-9867
Rachael NimmoDepartment of Cancer Biology, UCL Cancer Institute, London, UK.
Paolo SalomoniGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. Paolo.Salomoni@dzne.de.ORCID http://orcid.org/0000-0001-6885-8116
German Center for Neurodegenerative Diseases · DECRUK Lung Cancer Centre of Excellence · GBUniversity of Bonn · DELund University · SEQueen Mary University of London · GBSanford Burnham Prebys Medical Discovery Institute · USUniversity Hospital Bonn · DE

Funding

STRUCTURAL BASIS FOR EPIGENETICS IN AGING AND LONGEVITYP01AG031862 · NIA · WISTAR INSTITUTE · PI ADAMS, PETER D. · 2008 to 2022
$28.3M
Cancer Research UK C16420/A18066Cancer Research UK C33499/A20265Cancer Research UK C416/A25145Medical Research Council MC_U132670601NIA NIH HHS P01 AG031862
6 · The paper itself

Abstract

Defective silencing of retrotransposable elements has been linked to inflammageing, cancer and autoimmune diseases. However, the underlying mechanisms are only partially understood. Here we implicate the histone H3.3 chaperone Daxx, a retrotransposable element repressor inactivated in myeloid leukaemia and other neoplasms, in protection from inflammatory disease. Loss of Daxx alters the chromatin landscape, H3.3 distribution and histone marks of haematopoietic progenitors, leading to engagement of a Pu.1-dependent transcriptional programme for myelopoiesis at the expense of B-cell differentiation. This causes neutrophilia and inflammation, predisposing mice to develop an autoinflammatory skin disease. While these molecular and phenotypic perturbations are in part reverted in animals lacking both Pu.1 and Daxx, haematopoietic progenitors in these mice show unique chromatin and transcriptome alterations, suggesting an interaction between these two pathways. Overall, our findings implicate retrotransposable element silencing in haematopoiesis and suggest a cross-talk between the H3.3 loading machinery and the pioneer transcription factor Pu.1.

Indexed as

AnimalsAutoimmune DiseasesB-LymphocytesCell LineChromatinCo-Repressor ProteinsHematopoietic Stem CellsHistonesHumansInflammationLeukocyte DisordersMiceMice, Inbred C57BLMice, KnockoutMolecular ChaperonesMyelopoiesisChromatinCo-Repressor ProteinsDaxx protein, mouseHistonesMolecular ChaperonesProto-Oncogene ProteinsProto-Oncogene Protein Spi-1RetroelementsTrans-Activators

Identifiers

PMID34876685
PMCPMC8683376
OpenAlexW4200275329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.